BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8963159)

  • 1. Screening for tamoxifen ocular toxicity: a prospective study.
    Therssen R; Jansen E; Leys A; Rutten J; Meyskens J
    Eur J Ophthalmol; 1995; 5(4):230-4. PubMed ID: 8963159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular toxicity in low-dose tamoxifen: a prospective study.
    Noureddin BN; Seoud M; Bashshur Z; Salem Z; Shamseddin A; Khalil A
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():729-33. PubMed ID: 10707134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen-associated eye disease. A review.
    Nayfield SG; Gorin MB
    J Clin Oncol; 1996 Mar; 14(3):1018-26. PubMed ID: 8622006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen and ocular toxicity.
    Ah-Song R; Sasco AJ
    Cancer Detect Prev; 1997; 21(6):522-31. PubMed ID: 9398992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term tamoxifen citrate use and potential ocular toxicity.
    Gorin MB; Day R; Costantino JP; Fisher B; Redmond CK; Wickerham L; Gomolin JE; Margolese RG; Mathen MK; Bowman DM; Kaufman DI; Dimitrov NV; Singerman LJ; Bornstein R; Wolmark N
    Am J Ophthalmol; 1998 Apr; 125(4):493-501. PubMed ID: 9559735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen retinopathy. A case report.
    Costa RH; Dhooge MR; Van Wing F; De Rouck AF
    Bull Soc Belge Ophtalmol; 1990; 238():161-8. PubMed ID: 2131119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for ocular toxicity in asymptomatic patients treated with tamoxifen.
    Heier JS; Dragoo RA; Enzenauer RW; Waterhouse WJ
    Am J Ophthalmol; 1994 Jun; 117(6):772-5. PubMed ID: 7880223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patients.
    Pavlidis NA; Petris C; Briassoulis E; Klouvas G; Psilas C; Rempapis J; Petroutsos G
    Cancer; 1992 Jun; 69(12):2961-4. PubMed ID: 1591689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer: results from International Breast Cancer Study Group trials.
    Gianni L; Panzini I; Li S; Gelber RD; Collins J; Holmberg SB; Crivellari D; Castiglione-Gertsch M; Goldhirsch A; Coates AS; Ravaioli A;
    Cancer; 2006 Feb; 106(3):505-13. PubMed ID: 16369994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral optic neuritis evolved during tamoxifen treatment.
    Pugesgaard T; Von Eyben FE
    Cancer; 1986 Jul; 58(2):383-6. PubMed ID: 3719532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular toxicity of systemic medications: a case series.
    To TQ; Townsend JC
    Optometry; 2000 Jan; 71(1):29-39. PubMed ID: 10680416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinal changes associated with tamoxifen treatment for breast cancer.
    Tang R; Shields J; Schiffman J; Li H; Locher D; Hampton J; Prager T; Pardo G
    Eye (Lond); 1997; 11 ( Pt 3)():295-7. PubMed ID: 9373465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifocal electroretinography, color discrimination and ocular toxicity in tamoxifen use.
    Salomão SR; Watanabe SE; Berezovsky A; Motono M
    Curr Eye Res; 2007 Apr; 32(4):345-52. PubMed ID: 17453956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen-induced ocular toxicity.
    Mihm LM; Barton TL
    Ann Pharmacother; 1994 Jun; 28(6):740-2. PubMed ID: 7919565
    [No Abstract]   [Full Text] [Related]  

  • 15. Tamoxifen retinopathy.
    McKeown CA; Swartz M; Blom J; Maggiano JM
    Br J Ophthalmol; 1981 Mar; 65(3):177-9. PubMed ID: 7225310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory Tamoxifen-Induced Keratopathy Despite Drug Withdrawal.
    Andreanos K; Oikonomakis K; Droutsas K; Petrelli M; Kymionis G
    Cornea; 2017 Mar; 36(3):377-378. PubMed ID: 27918356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular toxicity of tamoxifen.
    Gerner EW
    Ann Ophthalmol; 1989 Nov; 21(11):420-3. PubMed ID: 2619152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular side-effects in breast cancer patients treated with tamoxifen and toremifene: a randomized follow-up study.
    Parkkari M; Paakkala AM; Salminen L; Holli K;
    Acta Ophthalmol Scand; 2003 Oct; 81(5):495-9. PubMed ID: 14510798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ocular toxicity induced by tamoxifen: an overview].
    Wang M; Ma J; Zhong Y
    Zhonghua Yan Ke Za Zhi; 2021 Mar; 57(3):232-236. PubMed ID: 33721964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen keratopathy as seen with in-vivo confocal microscopy.
    Tarafdar S; Lim LT; Collins CE; Ramaesh K
    Semin Ophthalmol; 2012; 27(1-2):27-8. PubMed ID: 22352823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.